“Phase 3 Trial Demonstrating High Efficacy, Favourable Safety, and Convenience of a Novel Calcipotriene and Betamethasone Dipropionate Cream” (2023) SKIN The Journal of Cutaneous Medicine, 7(2), p. s128. doi:10.25251/skin.7.supp.128.